References
- QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med201115517919121810710
- MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
- SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD –a review of potential interventionsInt J Chron Obstruct Pulmon Dis20094120322319554195
- NiciLDonnerCWoutersEAmerican Thoracic Society/European Respiratory Society (ATS/ERS). Statement on Pulmonary RehabilitationAm J Respir Crit Care Med2006173121390141316760357
- CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med200435041005101214999112
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global obstructive pulmonary disease Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosismanagement.html2011Accessed February 12, 2016
- GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
- ChungKFInflammatory mediators in chronic obstructive pulmonary diseaseCurr Drug Targets Inflamm Allergy20054661962517305518
- de TorresJPCordoba-LanusELópez-AguilarCC-reactive protein levels and clinically important predictive outcomes in stable COPD patientsEur Respir J200627590290716455829
- Pinto-PlataVMMullerovaHTosoJFFeudjo-TepieMSorianoJBVesseyRSCelliBRC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
- ScholsAMBuurmanWAStaal van den BrekelAJDentenerMAWoutersEFEvidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary diseaseThorax19965188198248795671
- BroekhuizenRWoutersEFCreutzbergECScholsAMRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax2006611172216055618
- de GodoyIDonahoeMCalhounWJMancinoJRogersRMElevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patientsAm J Respir Crit Care Med199615326336378564110
- HigashimotoYYamagataYTayaSSystemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differencesRespirology200813112813318197923
- TakabatakeNNakamuraHAbeSThe relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001614 Pt 11179118410764309
- YarnellJWSweetnamPMRumleyALoweGDLifestyle factors and coagulation activation markers: the Caerphilly StudyBlood Coagul Fibrinolysis200112872172811734674
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS Statement: Guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
- MahlerDWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
- AnthonisenNRWrightECHodgkinJEPrognosis in chronic obstructive pulmonary diseaseAm Rev Respir Dis1986133114203510578
- JonesPWQuirkFHBaveystockCMLittlejohnsPA selfcomplete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
- OngKCEarnestALuSJA multidimensional grading system (BODE index) as predictor of hospitalization for COPDChest200512863810381616354849
- MarinJMSanchezAAlonsoJEA multivariate grading system (BODE) as predictor of the severity of exacerbation in COPD (abstract)Am J Respir Crit Care Med2003167A23
- BeehKMBeierJKornmannOManderABuhlRLong-term repeatability of induced sputum cells and infl ammatory markers in stable, moderately severe COPDChest2003123377878312628878
- BalzanoGStefanelliFIorioCDe FeliceAMelilloEMMartucciMMelilloGEosinophilic infl ammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway functionAm J Respir Crit Care Med19991605 Pt 11486149210556110
- BonJMLeaderJKWeissfeldJLThe influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary diseasePLoS One200948e686519718453
- TanniSEPelegrinoNRAngeleliAYCorreaCGodoyISmoking status and tumor necrosis factor alpha mediated systemic inflammation in COPD patientsJ Inflamm (Lond)201072920534161
- Di FranciaMBarbierDMegeJLOrehekJTumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941505 Pt 1145314557952575
- SariogluNAlpaydinAOCoskunASCelikPOzyurtBCYorganciogluARelationship between BODE index, quality of life and inflammatory cytokines in COPD patientsMultidiscip Respir Med201052849122958780
- CosioMGSaettaMAgustiAImmunologic aspects of chronic obstructive pulmonary diseaseN Engl J Med2009360232445245419494220
- AldonyteRJanssonLPiitulainenEJanciauskieneSCirculating monocytes from healthy individuals and COPD patientsRespir Res200341114624669
- Pinto-PlataVCasanovaCMüllerovaHInflammatory and repair serum biomarker pattern: association to clinical outcomes in COPDRespir Res2012137122906131
- EickhoffPValipourAKissDDeterminants of systemic vascular function in patients with stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178121211121818836149
- GakiEKontogianniKPapaioannouAIAssociations between BODE index and systemic inflammatory biomarkers in COPDCOPD20118640841322149400